GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 320 filers reported holding GW PHARMACEUTICALS PLC in Q4 2019. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,261,000 | +167.5% | 19,647 | +42.3% | 0.85% | +56.5% |
| Q4 2020 | $1,593,000 | +46.7% | 13,806 | +23.8% | 0.54% | +34.8% |
| Q3 2020 | $1,086,000 | -2.0% | 11,151 | +23.5% | 0.40% | -2.2% |
| Q2 2020 | $1,108,000 | +48.9% | 9,027 | +6.2% | 0.41% | +47.8% |
| Q1 2020 | $744,000 | -4.2% | 8,496 | +14.3% | 0.28% | +35.6% |
| Q4 2019 | $777,000 | +93.8% | 7,434 | +113.4% | 0.20% | +241.7% |
| Q3 2019 | $401,000 | – | 3,483 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |